Henry Schein, Inc.  

(Public, NASDAQ:HSIC)   Watch this stock  
Find more results for HSIC
-2.24 (-1.49%)
Feb 5 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 147.33 - 150.15
52 week 126.17 - 161.62
Open 150.01
Vol / Avg. 471,357.00/511,144.00
Mkt cap 12.26B
P/E 25.94
Div/yield     -
EPS 5.70
Shares 82.93M
Beta 1.05
Inst. own 98%
Feb 24, 2016
Henry Schein Inc at RBC Capital Markets Healthcare Conference - 4:05PM EST - Add to calendar
Feb 11, 2016
Henry Schein Inc at Leerink Partners Global Healthcare Conference - 3:30PM EST - Add to calendar
Feb 10, 2016
Q4 2015 Henry Schein Inc Earnings Call - 10:00AM EST - Add to calendar
Feb 10, 2016
Q4 2015 Henry Schein Inc Earnings Release - 9:30AM EST - Add to calendar
Jan 12, 2016
Henry Schein Inc at JPMorgan Healthcare Conference
Dec 2, 2015
Henry Schein Inc at Piper Jaffray Healthcare Conference - Webcast
Dec 1, 2015
Henry Schein Inc at Nasdaq OMX Investor Program
Nov 18, 2015
Henry Schein Inc at Stifel Healthcare Conference
Nov 10, 2015
Henry Schein Inc at Credit Suisse Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 5.07% 4.76%
Operating margin 7.03% 6.90%
EBITD margin - 8.31%
Return on average assets 8.76% 8.39%
Return on average equity 17.66% 16.65%
Employees 17,500 -
CDP Score - -


135 Duryea Rd
United States - Map
+1-631-8435500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Henry Schein, Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products, laboratory products, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins, among others. The Company's global technology and value-added services segment provides software, technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners.

Officers and directors

Stanley M. Bergman Chairman of the Board, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Steven Paladino CPA Chief Financial Officer, Executive Vice President, Director
Age: 58
Bio & Compensation  - Reuters
James P. Breslawski CPA President, Henry Schein and Chief Executive Officer, Global Dental Group, Director
Age: 61
Bio & Compensation  - Reuters
David C. McKinley President, Medical Group
Age: 62
Bio & Compensation  - Reuters
Bob Minowitz President, International Dental Group
Age: 56
Bio & Compensation  - Reuters
Lonnie Shoff Chief Executive Officer of Global Animal Health and Strategic Partnership Group
Age: 56
Bio & Compensation  - Reuters
Gerald A. Benjamin Chief Administrative Officer, Executive Vice President, Director
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark E. Mlotek Chief Strategic Officer, Executive Vice President, Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James A. Harding Chief Technology Officer, Senior Vice President
Age: 59
Bio & Compensation  - Reuters
Leonard A. David Chief Compliance Officer, Senior Vice President
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance